Cue Biopharma Reports Second Quarter 2021 Results, Recent Data Updates of CUE-101 Phase 1 Dose Escalation and Expansion Study, Platform Progress and Business Highlights
CAMBRIDGE, Mass., Aug. 17, 2021 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage…
OpenEnvoy Launches Ask OE to Solve Enterprise Finance AI’s Foundational Problem
Fortinet launches Singapore NDR cloud PoP to strengthen threat detection across ASEAN